as confirmed by the market, the intellectual property issue is...

as confirmed by the market, the intellectual property issue is the key element to attribute value to the company. yesterday the announcement of the granting in America of one of the two specific patents for Pitt. but there is more and more important! Wednesday 25 June was declared the beginning of the research on possible overlaps or elements of litigation regarding the European patent on the composition of 2591, which is the basis of everything. this step is the prelude to the granting of the patent also in Europe. key event to consolidate and secure the intellectual property of Neuren, in a context in which there are negotiations underway, to define a reasonable price for a change of control.as anticipated in my previous post, by the 13th of this month we will have a substantial change in the shareholding that concerns our main managers. it is about almost 2 million shares, which have the objective of rewarding their work done so far. it seems clear to me and I have confirmation of it, that right in this period the communication to the market has restarted, on how much good is progressing. legitimate and realistic to expect news on a new hidden indication and update on the progress of phase 3 PMD, by the middle of next month.if everything comes back to normal, after the first week of August we could really start to discount the unpredictability of a takeover or a partnership, very different from the one signed in August 2018 with Acadiafinally and marginally, but not of lesser importance for "conspiracy theorists" like me, I remember that the modification of the agreement with Acadia with ROW concession and 2591 for FX/Rett was signed on July 14, 2023 (two years before the expiration of the options I was talking about). for those who know Neuren very well, nothing is left to chance or that can escape a methodical planning of events.

I wish everyone Good Luck